Hope Medical Enterprises, Inc. v. Fagron Compounding Services
Opinion
Opinion
NOT FOR PUBLICATION FILED
UNITED STATES COURT OF APPEALS DEC 10 2021
MOLLY C. DWYER, CLERK
U.S. COURT OF APPEALS
FOR THE NINTH CIRCUIT
HOPE MEDICAL ENTERPRISES, INC., No. 21-55165 d/b/a Hope Pharmaceuticals, D.C. No. Plaintiff-Appellee, 2:19-cv-07748-CAS-PLA
v.
MEMORANDUM*
FAGRON COMPOUNDING SERVICES,
LLC; et al.,
Defendants-Appellants.
Appeal from the United States District Court for the Central District of California Christina A. Snyder, District Judge, Presiding
Argued and Submitted November 17, 2021 Pasadena, California
Before: RAWLINSON and LEE, Circuit Judges, and KENNELLY,** District Judge.
Defendants Fagron Compounding Services, LLC, JCB Laboratories, LLC,
AnazaoHealth Corporation, and Coast Quality Pharmacy, LLC (collectively,
* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. ** The Honorable Matthew F. Kennelly, United States District Judge for the Northern District of Illinois, sitting by designation. “Fagron”) appeal the district court’s denial of their motion titled “Motion for